ReviewTherapeutic advances in urology
Urinary stone management during the COVID-19 pandemic: a suggested approach and review of literature.
Review in Therapeutic advances in urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Changes in Ureteral Stone Treatment During COVID-19: A Single-Center Emergency Department Study.Research and reports in urology · 2025Article
- Impact of Personnel Scarcity on Urolithiasis Treatment: A Comparative Study of the Pre- and Post-Pandemic Eras.Urologia internationalis · 2025Article
- Administering antibiotic-loaded irrigation fluid as an alternative for prophylactic intravenous antibiotics in transurethral ureterolithotripsy (TUL): a randomized controlled trial.American journal of clinical and experimental urology · 2024Article
- A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.Open medicine (Warsaw, Poland) · 2024Review
- Emergency Urology procedures during the COVID-19 pandemic in the UK: A 3-month prospective study.Urologia · 2023Article
- The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.Clinical genitourinary cancer · 2023Article
- Article
- The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation.BMC medical genomics · 2022Article
- A case of COVID-19 infection in a kidney transplant recipient after receiving the single dose of COVID-19 vaccination.Annals of medicine and surgery (2012) · 2022Article
- The development and application of a triage system for urolithiasis during COVID-19.World journal of urology · 2022Review
- Necrotizing Epididymo-Orchitis: A Rare Manifestation of COVID-19.Case reports in urology · 2022Article
- Urolithiasis treatment options during COVID-19 pandemic: review of current recommendations and triage systems.African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA) · 2020Review
- Pharmacotherapeutic approach toward urological medications and vaccination during COVID-19: a narrative review.Therapeutic advances in urologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is now the major health concern of the century in many countries. Prolonged homestay has various undesirable consequences for people, such as physical inactivity and weight gain, which potentially could put people at risk of urinary stone formation. With regard to the prevention and treatment strategy for urinary stones during this COVID-19 pandemic period, patients can be divided into two groups. The first group comprises those for whom urological intervention is not indicated and where general dietary and lifestyle recommendations are helpful. The second group comprises those patients where urological intervention is indicated. This group can be divided into emergent and nonemergent subgroups. Patients with urinary stones and concomitant uremia, sepsis, anuria, or refractory pain and vomiting make up the emergent group, where intervention is necessary. The preferred option during the novel coronavirus crisis for these patients is percutaneous nephrostomy tube insertion under local anesthesia. The second subgroup is made up of those patients with asymptomatic and noncomplicated renal and ureteral stones where urologic intervention is indicated in the usual time scale. However, we suggest conservative treatment for 3 months during the COVID-19 outbreak after which re-evaluation of the patient should be carried out. Thus the operation could be chosen carefully based on the patient's and urologist's preference and the rate of infection in that center.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.